The inhibition of matrix metalloproteinase enzymes

Chemistry and Industry (London)

Volumn , Issue 7, 1997, Pages 258-261

  Davidson, Alan H ^a   Drummond, Alan H ^a   Galloway, W Alan ^a   Whittaker, Mark ^a  

^a British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASES; NEW APPROACHES; PHARMACEUTICAL COMPANY;

ENZYME INHIBITION;

EID: 0346937703     PISSN: 00093068     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (67)

1. Van der Rest, M., & Garrone, R., FASEB. J., 1991, 5, 2814-23
2. Postlethwaite, A.E., & Kang, A.M., in 'Inflammation: basic principles and clinical correlates', (Eds J.I. Gallin, I.M. Goldstein & R. Snyderman), New York: Raven Press, 1992, 747-73
3. Fisher, S.J., & Damsky, C.H., Seminars Cell Biol., 1993, 4, 183-8
4. Saarialho-Kere, U.K., Pentland, A.P., Birkedal-Hansen, H., Parks, W.C., & Welgus, H.G., J. Clin. Invest., 1994, 94, 79-88
5. Woessner, Jnr, J.F., FASEB J., 1991, 5, 2145-54
6. Matrisian, L.M., Trends in Genetics, 1990, 6, 121-5
7. Woessner, Jnr, J.F., Ann. N. Y. Acad. Sci., 1994, 732, 11-21
8. Cawston, T.E., Pharmacol. Ther., 1996, 70, 163-82
9. Pei, D., Majmudar, G., & Weiss, S.J., J. Biol. Chem., 1994, 269, 25849-55
10. Sato, H., et al, Nature, 1994, 370, 61-5
11. Will, H., & Hinzmann, B., Eur. J. Biochem., 1995, 231, 602-8
12. Takino, T., Sato, H., Shinagawa, A., & Seiki, M., J. Biol. Chem., 1995, 270, 23013-20
13. Okada, A., et al, Proc. Natl Acad. Sci. USA, 1995, 92, 2730-4
14. Puente, X.S., Pendás, A.M., Llano, E., Velsco, G., & López-Otin, C., Cancer Res., 1996, 56, 944-9
15. Kleiner, Jnr, D.E., & Stetler-Stevenson, W.G., Curr. Opin. Cell Biol., 1993, 5, 891-7
16. Springman, E., Angleton, E.L., Birkedal-Hansen, H., & Van Wart, H.E., Proc. Natl Acad. Sci. USA, 1990, 87, 364-8
17. He, C., et al, ibid, 1989, 86, 2632-6
18. Overall, C.M., Ann. N. Y. Acad. Sci., 1987, 732, 51-64
19. Ray, J.M., & Stetler-Stevenson, W.G., Eur. Respir. J., 1994, 7, 2062-72
20. Walakovits, L.A., Moore, V.L., Bhardwaj, N., Gallick, G.S., & Lark, M.W., Arthritis Rheum., 1992, 35, 35-12
21. Dean, D.D., Pelletier-Martel, J., Pelletier, J.-P. Howell, D.S., & Woessner, Jnr, J.F., J. Clin. Invest., 1989, 84, 678-85
22. Hill, P.A., et al, Biochem. J., 1995, 308, 167-75
23. Armstrong, P.W., Moe, G.W., Howard, R.J., Grima, E.A., & Cruz, T.F., Canadian J. Cardiol., 1994, 10, 214-20
24. MacDougall, J.R., & Matrisian, L.M., Cancer Metastasis Rev., 1995, 14, 351-62
25. Kohn, E.C., Pharmac. Ther., 1991, 52, 235-44
26. Liotta, L.A., Scientific American, 1992, 34-41
27. Brown, P.D., Pharaceutical. News, 1995, 2, 29-32
28. Vincenti, M.P., Clark, I.M., & Brinckerhoff, C.E., Arthritis Rheum., 1994, 37, 1115-26
29. Brown, P.D., & Giavazzi, R., Ann. Oncol., 1995, 6, 967-74
30. Brown, P.D., Curr. Opin. Invest. Drugs, 1993, 2, 617-26
31. Johnson, W.H., Roberts, N.A., & Borkakoti, N., J. Enzyme Inhibition, 1987, 2, 21-2
32. Schwartz, M.A., & Van Wart, H.E., Prog. Med. Chem., 1992, 29, 271-334
33. Morphy, J.R., Millican, T.A., & Porter, J.R., Curr. Med. Chem., 1995, 2, 743-62
34. Beckett, R.P., Davidson, A.H., Drummond, A.H., Huxley, P., & Whittaker, M., Drug Discovery Today, 1996, 1, 16-26
35. Beckett, R.P., Exp. Opin. Ther. Patents, 1996, 6, 1305-15
36. Galardy, R.E., Drugs of the Future, 1993, 18, 1109-11
37. Campion, C., Davidson, A.H., Dickens, J.P., & Crimmin, M.J., PCT patent application WO9005719, 1990
38. Porter, J.R., et al, Bioorg. Med. Chem. Lett., 1994, 4, 2741-6
39. Drummond, A.H., paper given at the CHI conference on 'Protease inhibitors: new therapeutics and approaches', Baltimore, USA, November 1996
40. Patent evaluation, Exp. Opin. Ther. Patents, 1996, 6, 917-20
41. Montana, J., paper given at the CHI conference on 'Protease inhibitors: new therapeutics and approaches', Baltimore, USA, November 1996
42. Wood, J.M., paper given at the CHI conference on 'Protease inhibitors: new therapeutics and approaches', Baltimore, USA, November 1996
43. Gonnella, N.C., et al, Proc. Natl Acad. Sci. USA, 1995, 92, 462-6
44. Kluender, H.C.E., et al, PCT patent application WO9615906, 1996
45. Pharmaprojects PLUS, Richmond: PJB Publications, 1996
46. Lovejoy, B., et al, Science, 1994, 263, 375-7
47. Lovejoy, B., Hassell, A.M., Luther, M.A., Weigl, D., & Jordan, S.R., Biochemistry, 1994, 33, 8207-17
48. Stams, T., et al, Struct. Biol., 1994, 1, 119-23
49. Bode, W., et al, EMBO J., 1994, 13, 1263-9
50. Spurlino, J.C., et al, Proteins: Struct. Funct. Genet., 1994, 19, 98-109
51. Grams, F., et al, Eur. J. Biochem., 1995, 228, 830-41
52. Browner, M.F., Smith, W.W., & Castelhano, A.L., Biochemistry, 1995, 34, 6602-10
53. Grams, F., et al, Biochemistry, 1995, 34, 14012-20
54. Becker, J.W., et al, Protein Science, 1995, 41, 1966-76
55. Gooley, P.R., et al, J. Biomolecular NMR, 1996, 7, 8-28
56. Dhanaraj, V., et al, Structure, 1996, 4, 375-86
57. Wahl, R.C., et al, Bioorg. Med. Chem. Lett., 1995, 5, 349-52
58. Gowravaram, M.R., et al, J. Med. Chem., 1995, 38, 2570-81
59. Appelt, K., paper given at the 7th Cyprus Conference on New Methods in Drug Research, Cyprus, April 1996
60. Castelhano, A.L., et al, PCT patent application WO9616027, 1996
61. Lewis, E.J., et al, Poster P108 given at the British Pharmacological Society Summer Meeting, Bath, UK, July 1996
62. Wood, N.D., et al, Poster presentation P234 given at the British Pharmacological Society Summer Meeting, Bath, UK, July 1996
63. Anderson, I.C., Shipp, M.A., Docherty, A.J.P., & Teicher, B.A., Cancer Res., 1996, 56, 715-8
64. Malfetano, J., et al, Proc. Am. Soc. Clin. Oncol, 1996, 15, 283 (abstr. 674)
65. Rosemurgy, A., Harris, J., Langleben, A., Casper, E., & Allen, R., ibid, 1996, 15, 207 (abstr. 470)
66. Boasberg, P., et al, ibid, 1996, 15, 258 (abstr. 671)
67. Millar, A., & Brown, P, Ann. Oncol., 1996, 7 (suppl. 5), 123